While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a metformin-first and wait strategy is enough for this higher-risk population
As patents expire, biosimilar development creates opportunities for broader patient access and market expansion
Trans-differentiation of glioma cells to endothelial cells in vitro was demonstrated by culturing of glioma cancer stem cells in endothelial-promoting media, resulting in expression of pan-endothelial markers CD31, CD34 and vWF, formation of tubular structures and uptake of LDL [59, 77]
Studies, as mentioned above, do not currently have data past 68 weeks
For select services, we offer self-pay options with no insurance required
Physician-supervised semaglutide microdose longevity program